A2 Biotherapeutics

A2 Biotherapeutics

  • Founded: 2017
  • Location: Agoura Hills, CA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Multiple cancers
  • Drug types: ONC
  • Lead product: A2B530
  • Product link: https://www.a2bio.com/our-pipeline/
  • Funding: $71.5M B Oct 2020; $57M A Nov 2019


a2bio.com

linkedin.com

job board


Short description:

Immunotherapy

Drug notes:

A2B694 Clin0 multiple cancers; 3 undisclosed programs RD undisclosed

Long description:

A2 Biotherapeutics is designing novel cell therapies to treat serious illnesses. Therapeutics to treat cancers depend on methods to distinguish tumors from normal cells. A2 Bio is using their proprietary Tmod platform to innovate new treatments for solid tumors involving the immune system. The platform integrates multiple signals, overcoming conventional single-target therapies, and exploits tumor-specific vulnerabilities. The Tmod platform is robustly different from other cell therapy systems due to its tumor precision and efficacy by incorporating two receptors, an activator and a blocker, to modulate the immune system. As their platform is modular, A2 Bio is building a broad pipeline of both autologous and allogeneic cell therapies for many unexploited tumor targets.

Jobs:

A2 Biotherapeutics
Materials Management Associate I
Agoura Hills, California|9 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com